{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:12:20Z","timestamp":1789193540103,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","medical.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.mcna.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T17:58:12Z","timestamp":1462039092000},"page":"891-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Pharmacotherapy for Substance Use Disorders"],"prefix":"10.1016","volume":"100","author":[{"given":"Jared Wilson","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2016.03.011_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.10.014","article-title":"Stigma, discrimination and the health of illicit drug users","volume":"88","author":"Ahern","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"47","key":"10.1016\/j.mcna.2016.03.011_bib2","first-page":"1108","article-title":"Current cigarette smoking among adults\u2014United States, 2005\u20132013","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2016.03.011_bib3","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). 2013 National Survey on Drug Use and Health (NSDUH). Table\u00a02.41B\u2014Alcohol use in lifetime, past year, and past month among persons aged 18 or older, by demographic characteristics: percentages, 2012 and 2013. Available at: http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabsPDFWHTML2013\/Web\/HTML\/NSDUH-DetTabsSect2peTabs1to42-2013.htm#tab2.41b. Accessed November 7, 2015."},{"key":"10.1016\/j.mcna.2016.03.011_bib4","unstructured":"SAMHSA. 2013 National Survey on Drug Use and Health (NSDUH). Table\u00a02.46B\u2014alcohol use, binge alcohol use, and heavy alcohol use in the past month among persons aged 18 or older, by demographic characteristics: percentages, 2012 and 2013. Available at: http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabsPDFWHTML2013\/Web\/HTML\/NSDUH-DetTabsSect2peTabs43to84-2013.htm#tab2.46b. Accessed November 7, 2015."},{"key":"10.1016\/j.mcna.2016.03.011_bib5","unstructured":"Center for Behavioral Health Statistics and Quality. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health (HHS publication no. SMA 15\u20134927, NSDUH Series H-50). 2015. Available at: http:\/\/www.samhsa.gov\/data\/. Accessed November 7, 2015."},{"key":"10.1016\/j.mcna.2016.03.011_bib6","series-title":"The health consequences of smoking: a report of the Surgeon General","author":"US Department of Health and Human Services","year":"2004"},{"issue":"9682","key":"10.1016\/j.mcna.2016.03.011_bib7","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mcna.2016.03.011_bib8","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0277-9536(99)00411-6","article-title":"Chronic illicit drug use, health services utilization and the cost of medical care","volume":"50","author":"French","year":"2000","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.mcna.2016.03.011_bib9","unstructured":"Mumola CJ, Karberg JC. Drug use and dependence, state and federal prisoners, 2004. Bureau of Justice Statistics Special Report. 2006. NJC 213530. Available at: http:\/\/www.bjs.gov\/index.cfm?ty=pbdetail&iid=778. Accessed November 7, 2015."},{"key":"10.1016\/j.mcna.2016.03.011_bib10","unstructured":"US Department of Justice, National Drug Intelligence Center. Impact of drugs on society in national drug threat assessment 2010. 2010. Available at: http:\/\/www.justice.gov\/archive\/ndic\/pubs38\/38661\/drugImpact.htm#foot6. Accessed November 7, 2015."},{"issue":"1\u20133","key":"10.1016\/j.mcna.2016.03.011_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drugalcdep.2008.08.003","article-title":"Screening, brief intervention, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6\u00a0months later","volume":"99","author":"Madras","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mcna.2016.03.011_bib12","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.mcna.2016.03.011_bib13","unstructured":"National Institute on Drug Abuse. Treatment approaches for drug addiction. Available at: http:\/\/www.drugabuse.gov\/publications\/drugfacts\/treatment-approaches-drug-addiction. Accessed November 7, 2015."},{"issue":"10","key":"10.1016\/j.mcna.2016.03.011_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.mcna.2016.03.011_bib15","article-title":"Opioid antagonists for alcohol dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib16","first-page":"21","article-title":"Adoption and implementation of medications in addiction treatment programs","volume":"5","author":"Knudsen","year":"2011","journal-title":"J\u00a0Addict Med"},{"issue":"1\u20133","key":"10.1016\/j.mcna.2016.03.011_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.drugalcdep.2008.07.018","article-title":"Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty","volume":"99","author":"Mark","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"19","key":"10.1016\/j.mcna.2016.03.011_bib18","first-page":"532","article-title":"State-specific prevalence of current cigarette smoking and smokeless tobacco use among adults aged \u226518 years\u2014United States 2011\u20132013","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"10.1016\/j.mcna.2016.03.011_bib19","first-page":"381","article-title":"Tobacco Use among middle and high school students\u2014United States, 2011\u20132014","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.011_bib20","first-page":"103","article-title":"Vital signs: disparities in nonsmokers' exposure to secondhand smoke\u2014United States, 1999\u20132012","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2016.03.011_bib21","series-title":"The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General","author":"US Department of Health and Human Services","year":"2006"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.011_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000146.pub4","article-title":"Nicotine replacement therapy for smoking cessation","author":"Stead","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.011_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009329.pub2","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.011_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jama.2014.7195","article-title":"Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial","volume":"312","author":"Koegelenberg","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.mcna.2016.03.011_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.280","article-title":"Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial","volume":"313","author":"Ebbert","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2016.03.011_bib27","doi-asserted-by":"crossref","first-page":"h1109","DOI":"10.1136\/bmj.h1109","article-title":"Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis","volume":"350","author":"Thomas","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.011_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2016.03.011_bib29","unstructured":"Available at: https:\/\/www.chantix.com\/how-to-get#chantix-cost. Accessed February 9, 2016."},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000031.pub4","article-title":"Antidepressants for smoking cessation","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.011_bib31","doi-asserted-by":"crossref","first-page":"e27016","DOI":"10.1371\/journal.pone.0027016","article-title":"Suicidal behavior and depression in smoking cessation treatments","volume":"6","author":"Moore","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006219.pub2","article-title":"Interventions for preventing weight gain after smoking cessation","author":"Parsons","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.011_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J069v24n02_02","article-title":"Effectiveness of bupropion for smoking cessation during pregnancy","volume":"24","author":"Chan","year":"2005","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.mcna.2016.03.011_bib34","unstructured":"Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS prevalence & trends data [online]. 2015. Available at: http:\/\/www.cdc.gov\/brfss\/brfssprevalence\/. Accessed November 27, 2015."},{"key":"10.1016\/j.mcna.2016.03.011_bib35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1056\/NEJMcp042262","article-title":"Unhealthy alcohol use","volume":"352","author":"Saitz","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.03.011_bib36","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Alcohol use disorder. Available at: http:\/\/www.niaaa.nih.gov\/alcohol-health\/overview-alcohol-consumption\/alcohol-use-disorders. Accessed November 27, 2015."},{"issue":"10","key":"10.1016\/j.mcna.2016.03.011_bib37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archinte.162.10.1117","article-title":"Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial","volume":"162","author":"Daeppen","year":"2002","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1016\/j.mcna.2016.03.011_bib38","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/alcalc\/agm136","article-title":"A\u00a0randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence","volume":"43","author":"Laaksonen","year":"2008","journal-title":"Alcohol Alcohol"},{"issue":"9370","key":"10.1016\/j.mcna.2016.03.011_bib40","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.mcna.2016.03.011_bib41","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"9603","key":"10.1016\/j.mcna.2016.03.011_bib43","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.011_bib44","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.09.004","article-title":"Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis","volume":"78","author":"Torrens","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"17","key":"10.1016\/j.mcna.2016.03.011_bib47","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2016.03.011_bib48","series-title":"The physicians' guide to helping patients with alcohol problems","author":"National Institute on Alcohol Abuse and Alcoholism","year":"1995"},{"key":"10.1016\/j.mcna.2016.03.011_bib49","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2105\/AJPH.86.7.978","article-title":"Alcohol consumption among the elderly in a general population, Erie County, New York","volume":"86","author":"Mirand","year":"1996","journal-title":"Am J Public Health"},{"key":"10.1016\/j.mcna.2016.03.011_bib50","series-title":"2013 National survey on drug use and health: detailed tables","year":"2014"},{"issue":"26","key":"10.1016\/j.mcna.2016.03.011_bib51","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users - United States, 2002-2013","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2016.03.011_bib52","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The TEDS report: 2001-2011 national admissions to substance abuse treatment services. Rockville (MD): 2013. Available at: http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/TEDS2011St_Web\/TEDS2011St_Web\/TEDS2011St_Web.pdf. Accessed November 29, 2015."},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/SAR.S24800","article-title":"Problematic use of prescription-type opioids prior to heroin use among young heroin injectors","volume":"2","author":"Pollini","year":"2011","journal-title":"Subst Abuse Rehabil"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.011_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugpo.2011.05.014","article-title":"Initiation into prescription opioid misuse amongst young injection drug users","volume":"23","author":"Lankenau","year":"2012","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.011_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.011_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2016.03.011_bib57","series-title":"Buprenorphine","author":"Office of Diversion Control","year":"2013"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.011_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","author":"Minozzi","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"9776","key":"10.1016\/j.mcna.2016.03.011_bib59","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.mcna.2016.03.011_bib60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.294.8.961","article-title":"Methods of detoxification and their role in treating patients with opioid dependence","volume":"294","author":"O'Connor","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.011_bib61","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1360-0443.2006.01651.x","article-title":"Methadone in pregnancy: treatment retention and neonatal outcomes","volume":"102","author":"Burns","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.mcna.2016.03.011_bib62","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0376-8716(03)00062-0","article-title":"Use of buprenorphine in pregnancy: patient management and effects on the neonate","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mcna.2016.03.011_bib63","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2016.03.011_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"The transfer of drugs and other chemicals into human milk","volume":"108","author":"American Academy of Pediatrics Committee on Drugs","year":"2001","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.011_bib65","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00019442-200409000-00015","article-title":"Characteristics and treatment outcome of older methadone-maintenance patients","volume":"12","author":"Firoz","year":"2004","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T12:26:55Z","timestamp":1536755215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712516000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0025712516000419"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2016.03.011","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy for Substance Use Disorders","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}